2024 annual financial data
Krystal Biotech 2024 Operating margin
Krystal Biotech 2024 operating margin with verified reported values.
Direct answer
Operating margin was 22.61%.
Operating income was 65,695,000 USD and net income was 89,159,000 USD.
Operating cash flow was 123,420,000 USD.
Get free Krystal Biotech email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 290,515,000 USD
- Operating income
- 65,695,000 USD
- Net income
- 89,159,000 USD
- Operating cash flow
- 123,420,000 USD